 | Piracetam improves Alertness in normal, healthy humans and age-impaired persons. |
| Piracetam improves the condition of Alzheimer's Disease patients and Dementia patients: research |
| | | - | Piracetam increases Alertness (by an average of 50%) in Alzheimer's Disease and Dementia patients. | | - | Piracetam alleviates Depression (by an average of 32%) in Alzheimer's Disease and Dementia patients. | | - | Piracetam improves Memory (by an average of 45%) in Alzheimer's Disease and Dementia patients. | | - | Piracetam alleviates the Paranoia that often occurs during the progression of Alzheimer’s Disease. research | | - | Piracetam alleviates Sleep Disorders in Alzheimer's Disease and Dementia patients. |
|
| Piracetam alleviates Anxiety. research |
| Piracetam (1,200 - 2,400 mg per ay) alleviates the Learning difficulties associated with Attention Deficit Disorder (ADD). |
| Piracetam improves Attention Span in normal, healthy humans and age-impaired persons. |
| Piracetam regenerates the Central Nervous System. |
| Piracetam increases the number of Cholinergic Receptors (i.e. Receptors for Acetylcholine) in the brain by up to 40%: |
| | | - | Piracetam stimulates Muscarinic Receptors and increases the sensitivity of Muscarinic Receptors (i.e. it functions as a Muscarinic Receptor Agonist). research |
|
| Piracetam facilitates the Interhemispheric Flow of Information between the two hemispheres of the Brain (by stimulating the production of Adenosine Triphosphate in the Cerebral Cortex of the Brain). |
| Piracetam enhances Creativity (by improving the Interhemispheric flow of Information within the Corpus Callosum of the Brain). research |
| Piracetam improves Hearing in persons afflicted with (sudden) Deafness (hearing loss) - in some cases it improves hearing by up to 15 dB. |
| Piracetam has been tested and found to be extremely beneficial in the treatment of Down’s Syndrome (an unpublished clinical trial attests to its ability to cause improvement in motor development, mental development, speech, emotional development, scholastic achievement and EEG in Down’s Syndrome patients). research |
| Piracetam improves most aspects of Mental Function (including speed and accuracy of reading, Short-Term Memory and Verbal Memory) in Dyslexia patients (by stimulating the production of Adenosine Triphosphate (ATP) in the Corpus Callosum of the Brain and by improving the Interhemispheric flow of Information between the two hemispheres of the Brain). research |
| Piracetam improves most aspects of mental function in Epilepsy patients without interfering with anti-epileptic pharmaceutical drugs: research |
| | | - | Piracetam enhances the ability of some Anti-Epileptic Pharmaceutical Drugs (e.g. Carbamazepine) to protect against Seizures in Epilepsy patients. |
|
| Piracetam enhances the activities of the Hippocampus associated with Learning and Piracetam also impedes damage to the Neurons of the Hippocampus following Alcohol (ethanol) consumption and impedes the exacerbated destruction of hippocampal Neurons during the period immediately following Alcohol withdrawal after prolonged Alcohol consumption. research |
| Piracetam enhances the utilization of Oxygen within the Brain and enhances the Brain's recovery from Hypoxia (oxygen starvation). |
| Piracetam increases some aspects of human Intelligence. research |
| Piracetam improves Learning ability in normal, healthy humans and age-impaired persons (by influencing both the Hippocampus and Cerebral Cortex of the Brain). research |
| Piracetam improves Memory in normal, healthy humans and age-impaired persons (by increasing the synthesis of the Proteins responsible for Memory by Polyribosomes and by increasing the production of Polyribosomes themselves): research |
| | | - | Piracetam protects against Memory loss from physical injury and chemical poisoning. | | - | Piracetam improves Short Term Memory (including Spatial Memory research, an aspect of Short Term Memory that involves remembering one’s position in space). |
|
| Piracetam stimulates and increases the sensitivity of Muscarinic Receptors (i.e. it functions as a Muscarinic Receptor Agonist); Piracetam also increases the number of Muscarinic Receptors in the Frontal Lobe of the Brain (indicating that Piracetam may stimulate the growth of new Muscarinic Receptors in the Frontal Lobe). |
| Piracetam is currently recognized as the “treatment of choice” for Myoclonus. research |
| Piracetam rejuvenates aged and damaged Neurons in the Brain. |
| Piracetam alleviates the Paranoia that often occurs during the progression of Alzheimer’s Disease. research |
| Piracetam (4,800 mg per day) is an effective adjuvant treatment (combined with Speech Therapy) for the treatment of Speech Impairment (aphasia). research |
| Piracetam increases the body’s tolerance to Stress. research |
| Piracetam alleviates (acute) Tinnitus. |
| Piracetam (2,400 - 4,800 mg per day) counteracts Vertigo (by alleviating the underlying Hypoxia that is believed to be responsible for Vertigo). |
Synergism